• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Vericel Corporation - Common Stock (NQ:VCEL)

41.69 +1.30 (+3.22%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 24, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 779,692
Open 40.78
Bid (Size) 37.94 (100)
Ask (Size) 48.71 (1,100)
Prev. Close 40.39
Today's Range 40.55 - 42.13
52wk Range 28.95 - 43.57
Shares Outstanding 46,631,158
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Regenerative Medicine’s Next Chapter: Inside the Race to Make the Body Rebuild Itself
June 18, 2026
From Biotech Insider
Via GlobeNewswire
News headline image
The Quiet Revolution in Regenerative Medicine: From Replacing Tissue to Rebuilding It
June 16, 2026
From World Street Intelligence
Via GlobeNewswire

Performance

YTD
+17.1%
+17.1%
1 Month
+19.2%
+19.2%
3 Month
+26.0%
+26.0%
6 Month
+11.5%
+11.5%
1 Year
-0.3%
-0.3%

More News

Read More
Vericel Corp (NASDAQ:VCEL): Growth and Technical Setup Align for Potential Breakout ↗
June 16, 2026
Via Chartmill
News headline image
Vericel to Present at the 2026 Truist Securities MedTech Conference on Tuesday, June 16, 2026
June 09, 2026
From Vericel Corporation
Via GlobeNewswire
Vericel (NASDAQ:VCEL) Balances High Growth and Reasonable Valuation in Affordable Growth Screen ↗
June 04, 2026
Via Chartmill
News headline image
Vericel Revenue Jumped 20%. One Biotech Investor Just Reported Adding $63 Million More ↗
May 30, 2026
Via The Motley Fool
Topics Regulatory Compliance
Vericel Corp (NASDAQ:VCEL): A Prime Example of Affordable Growth ↗
May 09, 2026
Via Chartmill
Vericel Corp (NASDAQ:VCEL) Smashes Q1 Estimates, Raises Full-Year Outlook as MACI and Burn Care Surge ↗
May 07, 2026
Via Chartmill
News headline image
MediWound (MDWD) Q1 2026 Earnings Transcript ↗
May 27, 2026
Via The Motley Fool
News headline image
The Newest Name on Nasdaq Wants to Help the Body Rebuild Itself
May 22, 2026
From Energy Metal News
Via GlobeNewswire
News headline image
Vericel Q1 Earnings Call Highlights ↗
May 09, 2026
Via MarketBeat
Topics Earnings
Vericel Corp (NASDAQ:VCEL) Presents a Compelling Growth and Technical Setup Opportunity ↗
May 05, 2026
Via Chartmill
Vericel Corp (NASDAQ:VCEL) Emerges as a Top Affordable Growth Pick ↗
March 27, 2026
Via Chartmill
Vericel Corp (NASDAQ:VCEL) Presents a Compelling Growth and Breakout Case ↗
February 27, 2026
Via Chartmill
News headline image
Vericel (VCEL) Q1 2026 Earnings Transcript ↗
May 08, 2026
Via The Motley Fool
News headline image
Vericel Reports First Quarter 2026 Financial Results and Raises Full-Year Financial Guidance
May 07, 2026
From Vericel Corporation
Via GlobeNewswire
News headline image
Vericel to Report First-Quarter 2026 Financial Results on May 7, 2026
April 23, 2026
From Vericel Corporation
Via GlobeNewswire
News headline image
MediWound Reports BARDA Contract Award to Vericel for NexoBrid® Valued at up to $197 Million
April 02, 2026
From MediWound Ltd.
Via GlobeNewswire
Vericel Corp (NASDAQ:VCEL) Reports Q4 2025 Earnings In Line, Beats on Profitability ↗
February 26, 2026
Via Chartmill
News headline image
Vericel Announces BARDA Award Valued at up to $197 Million for Procurement and Advanced Development of NexoBrid
April 02, 2026
From Vericel Corporation
Via GlobeNewswire
News headline image
Vericel Announces FDA Approval of New State-of-the-Art Advanced Therapy Manufacturing Facility
March 04, 2026
From Vericel Corporation
Via GlobeNewswire
News headline image
Vericel to Present at Multiple Upcoming Investor Conferences
March 03, 2026
From Vericel Corporation
Via GlobeNewswire
News headline image
Vericel (VCEL) Q4 2025 Earnings Call Transcript ↗
February 26, 2026
Via The Motley Fool
Topics Earnings
News headline image
Vericel Reports Fourth Quarter and Full-Year 2025 Financial Results
February 26, 2026
From Vericel Corporation
Via GlobeNewswire
News headline image
Vericel to Report Fourth-Quarter and Full-Year 2025 Financial Results on February 26, 2026
February 12, 2026
From Vericel Corporation
Via GlobeNewswire

Frequently Asked Questions

Is Vericel Corporation - Common Stock publicly traded?
Yes, Vericel Corporation - Common Stock is publicly traded.
What exchange does Vericel Corporation - Common Stock trade on?
Vericel Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Vericel Corporation - Common Stock?
The ticker symbol for Vericel Corporation - Common Stock is VCEL on the Nasdaq Stock Market
What is the current price of Vericel Corporation - Common Stock?
The current price of Vericel Corporation - Common Stock is 41.69
When was Vericel Corporation - Common Stock last traded?
The last trade of Vericel Corporation - Common Stock was at 06/24/26 04:00 PM ET
What is the market capitalization of Vericel Corporation - Common Stock?
The market capitalization of Vericel Corporation - Common Stock is 1.94B
How many shares of Vericel Corporation - Common Stock are outstanding?
Vericel Corporation - Common Stock has 2B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap